MDRTBMultidrug-Resistant Tubercle Bacilli
References in periodicals archive ?
The increased prevalence of MDR-TB among foreign-born TB patients in the past decade, the very high prevalence of MDR-TB among recent emigrants from the Philippines and Vietnam, and the trend towards younger, new active and non-respiratory MDRTB cases have important implications for TB programming in Alberta and other major immigrant-receiving provinces of Canada (notably Quebec, Ontario and British Columbia).
From this study, it appears feasible to treat MDRTB patients effectively in India on the predominantly ambulatory RNTCP standardized regimen, with certain additional inputs into the existing health care system.
Given the decreased efficacy of second-line agents, treatment failures are more common when treating MDRTB.
Froman to the collaborative research team will greatly enhance Phage's efforts to commercialize it's products and to assist in the treatment of patients stricken with antibiotic-resistant strains of TB and MDRTB," stated Dr.
The present study focuses on the prevalence of MDRTB and pattern of drug resistance among category II pulmonary TB patients from a tertiary care centre and a primary care level centre in northern India.
Ndjeka said the national guidelines 'clearly stated' that the standardised regimen was for newly diagnosed MDRTB patients only.
MDRTB can be a result of failure of drug sensitive TB treatment with development of resistance (acquired MDR-TB) or direct transmission of an MDR strain (primary MDR).
TB patients, Total XDR isolates n (% of all TB patients, tested, isolates n (% of MDRTB Geographic region n ([dagger]) tested) patients) Industrialized nations ([double dagger]) 2,499 821 (32.
Unfortunately, clinical outcomes remain poor in SA, with <45% of MDRTB cases reported as treatment success (cure or completion).
Several outbreaks in the United States demonstrated the role that hospitals can play as focal points of MDRTB transmission (9-13), a phenomenon also seen in Europe, South America, South Africa, and Russia (14-16).
The programme has expanded the capacity for research that does not exist currently in most MDRTB facilities.
We evaluate the management of MDRTB in 5 resource-limited countries: Estonia, Latvia, Peru, the Philippines, and the Russian Federation.